- Filed
- May 8, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · May 6, 2026 | 118.16M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 116.69M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2025 | 122.76M sh |
| Dividends Paid | Q1 2026 · Mar 31, 2026 | $3.55M |
| Dividends Paid | Q1 2026 · Mar 31, 2025 | $3.44M |
| Capex | Q1 2026 · Mar 31, 2026 | $46.48M |
| Capex restated | Q1 2026 · Mar 31, 2025 | $66.53M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | −$69.38M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2025 | −$85.65M |
| Long Term Debt | Q1 2026 · Mar 31, 2026 | $3.79B |
| Long Term Debt | Q1 2026 · Dec 31, 2025 | $3.71B |
| Short Term Debt | Q1 2026 · Mar 31, 2026 | $25.43M |
| Short Term Debt | Q1 2026 · Dec 31, 2025 | $65.44M |
| Cash And Equivalents | Q1 2026 · Mar 31, 2026 | $37.86M |
| Cash And Equivalents | Q1 2026 · Dec 31, 2025 | $57.35M |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | −$122.46M |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | $21.32M |
| Current Liabilities | Q1 2026 · Mar 31, 2026 | $361.72M |
| Current Liabilities | Q1 2026 · Dec 31, 2025 | $410M |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $4.87B |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $4.8B |
| Current Assets | Q1 2026 · Mar 31, 2026 | $397.58M |
| Current Assets | Q1 2026 · Dec 31, 2025 | $484.01M |
| Total Assets | Q1 2026 · Mar 31, 2026 | $5.69B |
| Total Assets | Q1 2026 · Dec 31, 2025 | $5.75B |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | −$1.32 |
| Eps Diluted | Q1 2026 · Mar 31, 2025 | $0.89 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | −$1.32 |
| Eps Basic | Q1 2026 · Mar 31, 2025 | $0.95 |
| Sga Expense | Q1 2026 · Mar 31, 2026 | $3.55M |
| Sga Expense | Q1 2026 · Mar 31, 2025 | $5.11M |
| Revenue | Q1 2026 · Mar 31, 2026 | $188.36M |
| Revenue | Q1 2026 · Mar 31, 2025 | $96.16M |